Greater Cannabis Company (GCAN) Long-Term Debt Issuances (2017 - 2026)
Greater Cannabis Company's (GCAN) quarterly Long-Term Debt Issuances came in at $5000.0 in Q1 2026, down 98.0% quarter-over-quarter from $250000.0 in Q2 2021.
Greater Cannabis Company (GCAN) Long-Term Debt Issuances (2017 - 2026) Analysis & Trends
Greater Cannabis Company's Long-Term Debt Issuances history runs 6 years deep, the most recent figure standing at $5000.0 for Q1 2026.
- On a quarterly basis, Long-Term Debt Issuances changed N/A year-over-year to $5000.0 in Q1 2026; TTM through Mar 2026 was $255000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $3600.0, changed N/A from the prior year.
- Long-Term Debt Issuances retreated to $5000.0 in Q1 2026 per GCAN's latest filing, from $250000.0 in the prior quarter.
- Across five years, Long-Term Debt Issuances topped out at $5000.0 in Q1 2026 and bottomed at $5000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.64 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Greater Cannabis Company | 292,929.85 | 292,929.85 | - | 5,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,000.00 |
| Mar 31, 2026 | 5,000.00 |
| Jun 30, 2021 | 250,000.00 |
| Jun 30, 2021 | 250,000.00 |
| Mar 31, 2021 | 250,000.00 |
| Mar 31, 2021 | 250,000.00 |
| Dec 31, 2020 | -436,668.00 |
| Dec 31, 2020 | -436,668.00 |
| Sep 30, 2020 | -3,000.00 |
| Sep 30, 2020 | -3,000.00 |
| Jun 30, 2020 | 83,001.00 |
| Jun 30, 2020 | 83,001.00 |
| Mar 31, 2020 | 426,667.00 |
| Mar 31, 2020 | 426,667.00 |
| Mar 31, 2019 | 250,000.00 |
| Mar 31, 2019 | 250,000.00 |
| Sep 30, 2018 | -20,000.00 |
| Sep 30, 2018 | -20,000.00 |
| Jun 30, 2018 | 111,127.00 |
| Jun 30, 2018 | 111,127.00 |